MASIMO CORP
MASINasdaqHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.53B | $1.40B | $1.28B | $2.04B | $1.14B | $269.6M |
| Operating income | $310.0M | $63.0M | $166.0M | $210.0M | $255.8M | $69.0M |
| Net income | −$151.5M | −$304.9M | $81.5M | $143.5M | $53.4M | $64.5M |
| Total assets | $1.70B | $2.63B | $3.04B | $3.21B | $1.71B | — |
| Total liabilities | $977.7M | $1.57B | $1.68B | $1.87B | $304.9M | — |
| Equity | $721.2M | $1.05B | $1.36B | $1.34B | $1.41B | — |
| EPS (diluted) | $-2.80 | $-5.60 | $1.51 | $2.60 | $4.14 | $1.12 |
| Shares out. | 52.2M | 52.9M | 52.6M | 55.4M | 55.3M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 20.3%
- Net margin
- −9.9%
- Return on equity
- −21.0%
- Return on assets
- −8.9%
- Return on capital (ROCE)
- 23.4%
- Liabilities / assets
- 57.5%
- Debt / equity
- 1.36×
- Book value / share
- $13.82
- Revenue growth (YoY)
- 9.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- 6.71safe
- Accruals / assets
- −21.7%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 5 good- Reported a net loss
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.7M | 4.3 | -4.0% |
| Apr 30, 2026 | 3.9M | 6.1 | +1.7% |
| Apr 15, 2026 | 3.8M | 5.5 | +17.6% |
| Mar 31, 2026 | 3.2M | 1.7 | +21.2% |
| Mar 13, 2026 | 2.7M | 1.4 | -30.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder vote · Regulation FD disclosureMay 4, 2026
- Other material eventApr 23, 2026
- Entered a material agreement · Regulation FD disclosureFeb 17, 2026
- Results of operations · Regulation FD disclosureJan 12, 2026
- Regulation FD disclosureDec 3, 2025
- Entered a material agreement · Terminated a material agreement · New financial obligationDec 1, 2025
- Results of operations · Regulation FD disclosureNov 4, 2025
- Completed an acquisition or disposition · Regulation FD disclosureSep 23, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDMay 27, 2026
- SCHEDULE 13GMay 15, 2026
- SCHEDULE 13GMay 14, 2026
- SCHEDULE 13G/AMay 14, 2026
- 10-QMay 5, 2026
- 4FORM 4May 5, 2026
- 4FORM 4May 5, 2026
- 4FORM 4May 5, 2026
- 4FORM 4May 5, 2026
- 8-KFORM 8-KMay 4, 2026
- 10-K/AMay 1, 2026
- SCHEDULE 13G/AApr 30, 2026
- DEFA14AApr 23, 2026
- 8-KFORM 8-KApr 23, 2026
- DEFM14AApr 1, 2026